Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma

The Journal of Trauma
Deborah M SteinThomas M Scalea

Abstract

Traumatic brain injury (TBI) is the leading cause of death and disability after trauma. Coagulopathy is common in this patient population and requires rapid reversal to allow for safe neurosurgical intervention and prevent worsening of the primary injury. Typically reversal of coagulopathy is accomplished with the use of plasma. Recombinant factor VIIa (rFVIIa; NovoSeven, Novo Nordisk, Bagsvaerd, Denmark) has become increasingly used "off-label" in patients with neurosurgical emergencies to rapidly reverse coagulopathy. We hypothesized that the use of rFVIIa in this patient population would prove to be cost-effective as well as demonstrate clinical benefit. The trauma registry at the R Adams Cowley Shock Trauma Center was used to identify all coagulopatic trauma patients admitted between January 2002 and December 2007 with relatively isolated TBI (head Abbreviated Injury Scale score of >or=4). The medical records of patients were reviewed and demographics, injury-specific data, medications administered, laboratory values, blood product utilization, neurosurgical procedures, length of stay (LOS), discharge disposition, and outcome data were abstracted. Patients who received rFVIIa for reversal of coagulopathy were compared again...Continue Reading

References

May 1, 1993·Archives of Surgery·S R ShackfordP L Wolf
Sep 1, 1996·Archives of Surgery·F HulkaE H Frank
Dec 10, 1999·Lancet·G KenetU Martinowitz
Feb 15, 2000·The Journal of Head Trauma Rehabilitation·D J ThurmanJ E Sniezek
Sep 24, 2002·JAMA : the Journal of the American Medical Association·Jean Louis VincentUNKNOWN ABC (Anemia and Blood Transfusion in Critical Care) Investigators
Jul 10, 2003·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Benny SørensenJørgen Ingerslev
Sep 26, 2003·Journal of Neurosurgical Anesthesiology·Dimitar KaradimovViliyan Platikanov
Jan 17, 2004·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kate Traynor
Oct 30, 2004·The Journal of Trauma·Richard P DuttonThomas M Scalea
Dec 15, 2004·Mayo Clinic Proceedings·William D FreemanJames F Meschia
Feb 25, 2005·The New England Journal of Medicine·Stephan A MayerUNKNOWN Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators
Mar 9, 2005·Critical Care Medicine·David A ZygunChristopher J Doig
Sep 15, 2005·Neurocritical Care·David L BrodyMichael N Diringer
Sep 22, 2005·Neurocritical Care·Sherman C Stein, Douglas H Smith
Nov 9, 2005·Critical Care Medicine·Saqib I DaraOgnjen Gajic
Mar 15, 2006·The Journal of Trauma·David B CohenJack E Wilberger
May 5, 2006·Seminars in Thrombosis and Hemostasis·Ulla Hedner
Aug 18, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Celeste N RudisillBarbara Gail Macik
Sep 15, 2006·Current Surgery·Christopher E WhiteJohn B Holcomb
Sep 30, 2006·Stroke; a Journal of Cerebral Circulation·Stephanie R EarnshawJonathan Rosand
Oct 13, 2006·Clinical Neurology and Neurosurgery·Hamid EtemadrezaieBabak Ganjeifar
Dec 13, 2006·The Journal of Trauma·Sandro B RizoliHomer C Tien
Dec 23, 2006·Critical Care : the Official Journal of the Critical Care Forum·Sandro B RizoliUNKNOWN NovoSeven Trauma Study Group
Apr 5, 2007·Journal of Neurosurgery·Gregory W J Hawryluk, Michael D Cusimano
Apr 7, 2007·The Journal of Trauma·G O Rhys ThomasThomas M Scalea
May 15, 2007·The Journal of Trauma·Jeremy G PerkinsJohn B Holcomb
Aug 19, 2007·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Lynn UhrigPhilippe G Meyer
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Feb 20, 2008·Archives of Surgery·Eileen M BulgerRonald V Maier

❮ Previous
Next ❯

Citations

Feb 15, 2011·Intensive Care Medicine·Heiko LierMichael Bernhard
Sep 21, 2013·Current Neurology and Neuroscience Reports·Monisha A Kumar
Nov 26, 2010·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·David J Dries
Dec 3, 2014·Emergency Medicine Clinics of North America·Tara Ann Paterson, Deborah Michelle Stein
Jan 28, 2016·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·A E Berndtson, R Coimbra
Feb 1, 2011·British Journal of Haematology·Emma P DeLougheryThomas G DeLoughery
Apr 8, 2010·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Daniel K NishijimaJames F Holmes
Aug 25, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Aziz S AlaliAvery B Nathens
Oct 15, 2013·American Journal of Surgery·Bellal JosephPeter Rhee
Dec 21, 2016·Pharmacotherapy·Alexander H FlanneryJeremy D Flynn
Mar 29, 2013·The Annals of Pharmacotherapy·Gretchen M BrophyDonald F Brophy
Mar 16, 2017·Zhurnal voprosy neĭrokhirurgii imeni N. N. Burdenko·Yu V KhrapovD V Svistov
May 12, 2011·International Journal of Stroke : Official Journal of the International Stroke Society·Luca MasottiDomenico Prisco
Apr 18, 2018·The Journal of Trauma and Acute Care Surgery·Faisal JehanBellal Joseph
Sep 11, 2009·The Journal of Trauma·Carole L WhiteJean-Louis Caron
Dec 29, 2012·The Journal of Trauma and Acute Care Surgery·Bellal JosephPeter Rhee
Dec 22, 2011·Current Opinion in Anaesthesiology·William M Weightman, Neville M Gibbs
Dec 17, 2011·The Journal of Trauma·Paul T EngelsHomer C Tien
Jul 14, 2010·Current Opinion in Anaesthesiology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.